Andres Acosta, MD, PhD

Dr. Acosta is a physician, scientist, and obesity expert. He is board certified in Internal Medicine, Gastroenterology and Hepatology, and Obesity Medicine and Nutrition. Dr. Acosta holds an MD from Universidad San Francisco De Quito, Ecuador, and a PhD from University of Florida, Gainesville. Currently, he is an Associate Professor of Medicine and Consultant in Gastroenterology and Hepatology at the Mayo Clinic, Rochester, MN. He co-directs the Nutrition Obesity Research Program and directs the Precision Medicine for Obesity Program at Mayo Clinic. Dr. Acosta’s goal is to treat and ultimately cure obesity, which he considers this century’s health epidemic. Dr. Acosta’s research focuses on precision medicine for obesity with the aim to identify the right therapy for the right patient, minimizing side effects. His research is supported by the National Institute of Health, many foundations and industry. He is a recognized national and international obesity and cardiometabolic disease expert with many patents, more than 145 peer-reviewed publications, including publications in the Lancet, Cell Metabolism, Gut and Gastroenterology, and many book chapters. His work has been featured in the New York Times, Time, CNN, NPR, among others. He won the 40-under-40 innovation award at Minneapolis Business Journal 2020 and Tekne Award (Winners exemplify Technology Innovation in Minnesota). He co-founded Phenomix Sciences and launched the first-of-its-kind diagnostic test to predict response to GLP-1s and other obesity/metabolic interventions. This invention was featured by Time Magazine as one of the best inventions of 2024.